TriomicsTriomics
Triomics

Triomics

AI-powered platform for drug discovery and development, accelerating research with advanced analytics.

2021Active67
Advertise here
About
Triomics is a biotechnology company leveraging artificial intelligence to accelerate drug discovery and development. Their platform integrates multi-omics data with advanced computational methods to identify novel therapeutic targets and predict drug efficacy, aiming to significantly reduce the time and cost of bringing new medicines to market.

Technology stack

detected 2026-06-03
Est. monthly stack spend~$520/mo
CDN
Cloudflare
Emailunknown
Stack
Webflow
Performance

Company Timeline

Capital network
Open in Market Map editor
Frequently asked

What does Triomics do?

Triomics is a biotechnology company leveraging artificial intelligence to accelerate drug discovery and development. Their platform integrates multi-omics data with advanced computational methods to identify novel therapeutic targets and predict drug efficacy, aiming to significantly reduce the time and cost of bringing new medicines to market.

How much funding has Triomics raised?

Triomics has raised a total of $37M in funding. The most recent round on record is Series B.

Where is Triomics headquartered?

Triomics is headquartered in Cambridge, United States.

When was Triomics founded?

Triomics was founded in 2021.

What industry does Triomics operate in?

Triomics operates in Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design, Genomics, Foundation Model.

How many employees does Triomics have?

Triomics has approximately 67 people on record.